Your search returned 3 results.

Results
	1.	P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. MedStar authors: Gallagher, Christopher PMID: 37148492 Year: 2023 Citation: Targeted Oncology. 18(3):321-326, 2023 May. Institution: Washington Cancer Institute Medline publication type: Letter Observational Study Form of publication: Journal Article All authors: Brufsky A, Gallagher C DOI: https://dx.doi.org/10.1007/s11523-023-00968-4 Add to cart (remove)
	2.	P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. MedStar authors: Gallagher, Christopher PMID: 37148492 Year: 2023 Citation: Targeted Oncology. 18(3):321-326, 2023 May. Institution: Washington Cancer Institute Medline publication type: Letter Observational Study Form of publication: Journal Article All authors: Brufsky A, Gallagher C DOI: https://dx.doi.org/10.1007/s11523-023-00968-4 Add to cart (remove)
	3.	Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors: Blackburn, Matthew J Chitalia, Ami Dilawari, Asma Gallagher, Christopher Lynce, Filipa Mohebtash, Mahsa Tiwari, Shruti R PMID: 34157782 Year: 2021 Citation: Cancer. 127(19):3622-3630, 2021 10 01. Institution: MedStar Franklin Square Cancer Center at Loch Raven Campus MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology & Oncology Fellowship Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R DOI: https://dx.doi.org/10.1002/cncr.33620 Add to cart (remove)

Powered by Koha